US2022022433A1PendingUtilityA1

Method for developing organ that lacks specific functional cell

60
Assignee: PORMEDTEC CO LTDPriority: Sep 19, 2017Filed: Oct 6, 2021Published: Jan 27, 2022
Est. expirySep 19, 2037(~11.2 yrs left)· nominal 20-yr term from priority
A01K 2207/12A01K 2227/108A01K 67/0275C12N 15/8778A01K 67/0271A01K 2267/025A01K 67/027A01K 2217/054A01K 2207/10
60
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Provided is a method for developing a secondary organ by using a non-human animal in which organ formation is inhibited, for the purpose of establishing a process for producing a functional cell such as a β cell within the body of an animal such as a pig, the method including the step of raising a newborn or a fetus of the non-human animal in which organ formation is inhibited by complementing at least a part of the function of the organ whose formation is inhibited.

Claims

exact text as granted — not AI-modified
1 - 18 . (canceled) 
     
     
         19 . A method for establishment and growth of a progenitor cell of a specific functional cell or a pluripotent stem cell, or a functional cell derived therefrom, comprising transplanting the progenitor cell or the pluripotent stem cell into an organ-like tissue, wherein the organ-like tissue is formed by a newborn or a fetus of a genetically modified pig and lacks a functional cell derived from the pig. 
     
     
         20 . The method according to  claim 19 , wherein the progenitor cell of the functional cell or the pluripotent stem cell is a human-derived cell. 
     
     
         21 . A material in which a progenitor cell of a specific functional cell or a pluripotent stem cell, or a functional cell derived therefrom is established and grown, the material lacking a functional cell derived from the pig and comprising organ-like tissue formed by a newborn or a fetus of a genetically modified pig, wherein the progenitor cell or the pluripotent stem cell is transplanted into the organ-like tissue. 
     
     
         22 . The material according to  claim 21 , wherein the progenitor cell of the functional cell or the pluripotent stem cell is a human-derived cell.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.